Background: Asymptomatic infection seems to be a notable feature of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen that causes coronavirus …

Background There is disagreement about the level of asymptomatic severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection. We conducted a living systematic review …

INTRODUCTION As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic continues, the deployment of safe and effective vaccines presents a key …

For COVID-19, it is vital to understand if quarantines shorter than 14 days can be equally
effective with judiciously deployed testing. Here, we develop a mathematical model that …

Background Whether young adults who are infected with SARS-CoV-2 are at risk of
subsequent infection is uncertain. We investigated the risk of subsequent SARS-CoV-2 …

Patients with hematologic malignancies have an increased risk of severe COVID‐19
infection. Vaccination against COVID‐19 is especially important in these patients, but …

Background Debate about the level of asymptomatic Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2) infection continues. The amount of evidence is increasing and …

BACKGROUND Despite guidelines promoting the prevention and aggressive treatment of
ventilator-associated pneumonia (VAP), the importance of VAP as a driver of outcomes in …

Quantification of asymptomatic infections is fundamental for effective public health
responses to the COVID-19 pandemic. Discrepancies regarding the extent of …

In less than two decades, three deadly zoonotic coronaviruses, severe acute respiratory
syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS …